Targeting S1P1 Receptor Protects against Murine Immunological Hepatic Injury through Myeloid-Derived Suppressor Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting S1P1 Receptor Protects against Murine Immunological Hepatic Injury through Myeloid-Derived Suppressor Cells

Published:2014-02-24 Issue:7 Volume:192 Page:3068-3079
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Liu Guangwei,Bi Yujing,Wang Ruoning,Yang Hui,Zhang Yan,Wang Xiao,Liu Huanrong,Lu Yun,Zhang Zhengguo,Chen Wanna,Chu Yiwei,Yang Ruifu

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference59 articles.

1. Chemoprevention strategies for pancreatic cancer.;Stan;Nat. Rev. Gastroenterol. Hepatol.,2010

2. Current and novel immunosuppressive therapy for autoimmune hepatitis

3. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines

4. Immunoregulatory cytokines in chronic hepatitis C virus infection: Pre- and posttreatment with interferon alfa

5. Silibinin protects mice from T cell-dependent liver injury☆

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Fingolimod on Renal Ischemia/Reperfusion Injury in a Rat Model;Current Molecular Pharmacology;2023-11-01

2. The role of sphingosine-1-phosphate in autophagy and related disorders;Cell Death Discovery;2023-10-18

3. Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis;Journal of Neuroinflammation;2022-11-19

4. Peripheral Myeloid-Derived Suppressor Cells are good biomarkers of the efficacy of Fingolimod in Multiple Sclerosis;2022-08-23

5. Therapeutic Strategy for Rheumatoid Arthritis by Induction of Myeloid-Derived Suppressor Cells with High Suppressive Potential;Biological and Pharmaceutical Bulletin;2022-08-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3